Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd.SSE: 603896

(603896)"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Conversion Results of "Shouxiangu 22 Convertible Bonds" and Share Changes

· Issued by Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603896 · · 3 pages · Chinese

Summary by 6ix AI

The report details the total amount converted and the number of shares created from the conversion, indicating minimal activity during the specified period. It also outlines the current status of the remaining convertible bonds that have not yet been converted. The filing confirms that the total share capital remains unchanged due to no conversions occurring in the latest quarter.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603896zhejiang-shouxiangu-pharmaceutical-co-ltdannouncement-on-conversion-results-of-shouxiangu-22-convertible-bonds-and-share-changes

Release

Announcement on Conversion Results of "Shouxiangu 22 Convertible Bonds" and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix

Story so far

Earlier from Zhejiang Shouxiangu Pharmaceutical

Later from Zhejiang Shouxiangu Pharmaceutical

All Zhejiang Shouxiangu Pharmaceutical news releases